The ICH M7(R2) Guideline (2023) continues to recommend the bacterial reverse mutation assay (Ames test), conducted in accordance with OECD 471, as …
In the ever-evolving landscape of pharmaceutical regulations, staying abreast of the latest guidelines is crucial for ensuring the safety and efficacy of …
A new paper, “Data-driven federated learning in drug discovery with knowledge distillation”, was recently published in Nature Machine Intelligence, the leading journal …
At Lhasa we know that there are many challenges involved in carrying out risk assessments for drug substances and drug products, to …
The Brazilian Health Regulatory Agency (Anvisa) has introduced RDC 964/2025, a new guidance that outlines in more detail the requirements for conducting …
The 2024 Richard Williams Memorial Award was proudly presented during the 37th annual Industrial Genotoxicology Group (IGG) meeting in Cambridge last December. …